Nicoccino Holding AB (”Nicoccino Holding” or ”Company”) has been approved for listing on NASDAQ OMX First North. The Company has established a Company Description that has been approved by NASDAQ OMX First North and will be available at the Company’s website, investor.nicoccino.se from June 24th 2014.
The Company’s share will be traded at First North as from June 27th, 2014. The share’s ticket symbol is ”NICO”. The ISIN-code is SE0005506185.
The Company’s proprietary product Nicoccino™ is an innovative and discrete nicotine product that quickly delivers nicotine to the user without the detrimental side effects of traditional tobacco products. The primary purpose of the product is to offer smokers an attractive alternative when they don’t want or can’t smoke.
Nicoccino™ is the result of ten years of research and development. The product is wafer thin about the size of half a stamp. In addition to pure medicinal nicotine, Nicoccino™ mainly consists of an alginate extracted from brown seaweed. It is flavored with natural oils and all other ingredients are pharmaceutical graded. Nicoccino™ contains no tobacco, no tar and has no smell.
Nicoccino™ will initially be launched on the UK market and sold online on http://www.nicoccino.co.uk, managed by our fully owned subsidiary Nicoccino Ltd.
Nicoccino Holding has appointed Remium Nordic AB to Certified Adviser.
For more information please contact,
Michael Bracké, CEO
Tel +46 707 45 95 75
e-mail: michel.bracke@niciccino.co.uk
For further information, please visit our corporate website investor.nicoccino.se
Press release (PDF)